Successful Treatment of Human Monocytic Ehrlichiosis with Rifampin

Currently recommended treatment regimens for human monocytic ehrlichiosis (HME) include doxycycline or tetracycline. Antibiotic susceptibility studies demonstrate that rifampin has in vitro bactericidal activity against Ehrlichia. Case reports have suggested clinical response with rifampin treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Abusaada, Khalid, Ajmal, Saira, Hughes, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2016
Materias:
Infectious Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744069/
https://www.ncbi.nlm.nih.gov/pubmed/26918212
http://dx.doi.org/10.7759/cureus.444
_version_ 1782414439979417600
author Abusaada, Khalid
Ajmal, Saira
Hughes, Laura
author_facet Abusaada, Khalid
Ajmal, Saira
Hughes, Laura
author_sort Abusaada, Khalid
collection PubMed
description Currently recommended treatment regimens for human monocytic ehrlichiosis (HME) include doxycycline or tetracycline. Antibiotic susceptibility studies demonstrate that rifampin has in vitro bactericidal activity against Ehrlichia. Case reports have suggested clinical response with rifampin treatment of human granulocytic anaplasmosis (HGA). We report the first case of HME successfully treated with rifampin.
format Online
Article
Text
id pubmed-4744069
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-47440692016-02-25 Successful Treatment of Human Monocytic Ehrlichiosis with Rifampin Abusaada, Khalid Ajmal, Saira Hughes, Laura Cureus Infectious Disease Currently recommended treatment regimens for human monocytic ehrlichiosis (HME) include doxycycline or tetracycline. Antibiotic susceptibility studies demonstrate that rifampin has in vitro bactericidal activity against Ehrlichia. Case reports have suggested clinical response with rifampin treatment of human granulocytic anaplasmosis (HGA). We report the first case of HME successfully treated with rifampin. Cureus 2016-01-01 /pmc/articles/PMC4744069/ /pubmed/26918212 http://dx.doi.org/10.7759/cureus.444 Text en Copyright © 2016, Abusaada et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Infectious Disease
Abusaada, Khalid
Ajmal, Saira
Hughes, Laura
Successful Treatment of Human Monocytic Ehrlichiosis with Rifampin
title Successful Treatment of Human Monocytic Ehrlichiosis with Rifampin
title_full Successful Treatment of Human Monocytic Ehrlichiosis with Rifampin
title_fullStr Successful Treatment of Human Monocytic Ehrlichiosis with Rifampin
title_full_unstemmed Successful Treatment of Human Monocytic Ehrlichiosis with Rifampin
title_short Successful Treatment of Human Monocytic Ehrlichiosis with Rifampin
title_sort successful treatment of human monocytic ehrlichiosis with rifampin
topic Infectious Disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744069/
https://www.ncbi.nlm.nih.gov/pubmed/26918212
http://dx.doi.org/10.7759/cureus.444
work_keys_str_mv AT abusaadakhalid successfultreatmentofhumanmonocyticehrlichiosiswithrifampin
AT ajmalsaira successfultreatmentofhumanmonocyticehrlichiosiswithrifampin
AT hugheslaura successfultreatmentofhumanmonocyticehrlichiosiswithrifampin

Ejemplares similares